Ann: Cynata Annual General Meeting Presentation, page-42

AO is projected to be 11.6 bill 10% of that market iiisss,


the numbers behind this game are huge, asthma etc are gonna be bigger whilst it’s easy to say close a deal the small print the 1% the upfronts/ milestones they all play a game in the end story. Then you add who wants it more who suits us better who can’t achieve successful market application it all becomes very complicated. Then add can we get more is stem cell application widely accepted and is safe long term what can we charge.
Hurry up and sign a deal doesn’t become that easy anymore, whilst we want deals we want fair value to the right partner